Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05114668
Title Safety, Tolerability, and Pharmacokinetics of EVT801 in Patients With Advanced Solid Tumours
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Kazia Therapeutics Limited
Age Groups: adult | senior
Covered Countries FRA

No variant requirements are available.